185 related articles for article (PubMed ID: 35581263)
41. Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
Yan C; Ma Y; Li J; Chen X; Ma J
Hum Vaccin Immunother; 2023 Aug; 19(2):2254239. PubMed ID: 37799074
[TBL] [Abstract][Full Text] [Related]
42. Integrated genomic and molecular characterization of cervical cancer.
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Nature; 2017 Mar; 543(7645):378-384. PubMed ID: 28112728
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
[TBL] [Abstract][Full Text] [Related]
44. Metabolism-associated molecular classification of cervical cancer.
Zhao M; Zhang X; Huan Q; Dong M
BMC Womens Health; 2023 Oct; 23(1):555. PubMed ID: 37884919
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
46. S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior
Zhao YC; Wang TJ; She LZ; Cui J; Zhang CH
J Cancer; 2023; 14(15):2931-2945. PubMed ID: 37781076
[No Abstract] [Full Text] [Related]
47. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
[TBL] [Abstract][Full Text] [Related]
48. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
[TBL] [Abstract][Full Text] [Related]
49.
Zhang YT; Xu LJ; Li L
Genet Test Mol Biomarkers; 2024 Jan; 28(1):10-21. PubMed ID: 38294357
[No Abstract] [Full Text] [Related]
50. Comprehensive analysis of ceRNA networks in HPV16- and HPV18-mediated cervical cancers reveals XIST as a pivotal competing endogenous RNA.
Berti FCB; Mathias C; Garcia LE; Gradia DF; de Araújo-Souza PS; Cipolla GA; de Oliveira JC; Malheiros D
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166172. PubMed ID: 34048924
[TBL] [Abstract][Full Text] [Related]
51. Construction and Analysis of lncRNA-Mediated ceRNA Network in Cervical Squamous Cell Carcinoma by Weighted Gene Co-Expression Network Analysis.
Chen W; Chen X; Wang Y; Liu T; Liang Y; Xiao Y; Chen L
Med Sci Monit; 2019 Apr; 25():2609-2622. PubMed ID: 30965350
[TBL] [Abstract][Full Text] [Related]
52. Predictive value of protease-activated receptor-2 (PAR
He S; Xu M; Xiong Z; Hu Y; Huo Q; Lu J; Lin Y; Yang L
J Cell Mol Med; 2021 Feb; 25(3):1415-1424. PubMed ID: 33369107
[TBL] [Abstract][Full Text] [Related]
53. Deciphering the Role of ERBB3 Isoforms in Renal Cell Carcinoma: A Comprehensive Genomic and Transcriptomic Analysis.
Kim M; Lee HH; Won SD; Jang Y; Kim BG; Cho NH; Choi YD; Chung JS; Han HH
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38276060
[TBL] [Abstract][Full Text] [Related]
54. Analysis of differentially expressed long non‑coding RNAs revealed a pro‑tumor role of MIR205HG in cervical cancer.
Yin L; Zhang Y; Zheng L
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878159
[TBL] [Abstract][Full Text] [Related]
55. Tumor purity as a prognosis and immunotherapy relevant feature in cervical cancer.
Deng Y; Song Z; Huang L; Guo Z; Tong B; Sun M; Zhao J; Zhang H; Zhang Z; Li G
Aging (Albany NY); 2021 Nov; 13(22):24768-24785. PubMed ID: 34844217
[TBL] [Abstract][Full Text] [Related]
56. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
[TBL] [Abstract][Full Text] [Related]
57. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer.
Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y
Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071
[TBL] [Abstract][Full Text] [Related]
58. Hypoxia-inducible miR-152 suppresses the expression of WNT1 and ERBB3, and inhibits the proliferation of cervical cancer cells.
Tang XL; Lin L; Song LN; Tang XH
Exp Biol Med (Maywood); 2016 Jul; 241(13):1429-37. PubMed ID: 26515145
[TBL] [Abstract][Full Text] [Related]
59. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
60. ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis.
Dahlhoff M; Schäfer M; Muzumdar S; Rose C; Schneider MR
Mol Oncol; 2015 Nov; 9(9):1825-33. PubMed ID: 26194695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]